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Karl B Landorf1,3*, Hylton B Menz1, Alan M Borthwick2, Mike J Potter2, Shannon E Munteanu1,3
and Catherine J Bowen2Health research published in journals provides an ever-
increasing number of studies and trials that espouse the
benefits of all sorts of interventions. But how do con-
sumers of research, for example the readers of Journal of
Foot and Ankle Research (JFAR), know whether to believe
the findings of research articles that they read? Clearly,
health journals have an unambiguous responsibility to
support good quality research that provides believable
findings. Equally, they also have a responsibility to filter
out poor quality research that provides findings that are
not believable.
JFAR steadfastly supports good quality research and the
editorial team (with the assistance of the peer-reviewers)
work conscientiously to publish only those studies that
are of the highest quality; that is, studies with believable
findings. While this is not always easy, and the goal
posts that define quality of research are constantly being
repositioned, the editors strive to bring the readers of
JFAR the best foot and ankle research. Unfortunately,
not all studies use perfect methods, so if a study does
have limitations and is published, then the editors are
careful to ensure that the authors clearly acknowledge
the limitations in their articles, affording readers an
insight into the pitfalls of the study.
To assist the editors in this task, there is a burgeoning
array of guidelines and recommendations for the con-
duct and reporting of different study designs. For
example, there are the CONsolidated Standards Of
Reporting Trials (CONSORT) Statement [1] and the
Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) Statement [2]. Each guide-
line has been developed to ensure that important as-
pects of a trial or review are reported by the authors.
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stated.item in the guideline, which covers key aspects of a
study (e.g. blinding, sample size determination and
statistical analysis) that authors should report to ensure
that they have included essential pieces of information,
which ultimately makes the study’s findings more believ-
able. That is, it prevents authors from deceiving the reader,
by concealing that they did not do something they should
have, or equally bad, done something that they should
not have.
As an added bonus to readers of such articles, if
guidelines like CONSORT and PRISMA are followed
they invariably make an article less ambiguous and much
easier to understand what has occurred in the study. The
developers of such guidelines are experts, with most
having decades of highly active experience researching
and practicing these study designs. They are also gener-
ous individuals that have provided the guidelines in con-
sumer friendly packages that are freely available. Potential
users of these guidelines can easily access them through
the well-developed CONSORT [3] and PRISMA [4] web-
sites. Further to the guidelines mentioned above, there are
many others for different study designs, for example; the
Guidelines for Reporting Reliability and Agreement Stud-
ies (GRRAS) [5] and the Strengthening the Reporting of
Observational Studies in Epidemiology (STROBE) state-
ment [6,7]. Authors are recommended to consult these
where appropriate and an excellent resource when writing
manuscripts is that of the Enhancing the QUAlity and
Transparency Of health Research (EQUATOR) Network
[8], which is a virtual one-stop shop for guidelines that are
relevant to publishing in health science journals. The
EQUATOR Network includes guidelines for both quanti-
tative and qualitative research.
JFAR, as a BioMed central journal, adheres to these
guidelines and authors of studies that use these study de-
signs are obliged to include such checklists upon submis-
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JFAR is setting the benchmark in this area because the
editors believe that it leads to the highest possible quality
research articles for its readers, and consequently the most
believable findings will be presented in JFAR.
Furthermore, if clinical trials – where participants re-
ceive an intervention that is evaluated – are considered
in more detail, JFAR also demands that authors must
register their trial with a recognised clinical trial regis-
try. Ideally, clinical trials should be registered prior to
recruitment. Up to now, JFAR has accepted clinical tri-
als that have been registered with a recognised clinical
trial registry after the first participant has been re-
cruited. However, from now on, JFAR will only accept
clinical trials that are registered prior to recruitment.
Why is this important? To begin with, it means that all
clinical trials can be tracked and the results of clinical
trials are less likely to be not published, which occurs
more frequently in ‘non-significant trials’ (where no dif-
ference is detected between interventions). However, an
equally important reason is that it prevents investigators
changing their protocol or analysis in light of their find-
ings if they unwisely assess the results prior to the comple-
tion of the trial, or once they have evaluated the results
but before publication (often referred to as over-analysing
the data or “cherry-picking” the results, which results in
bias). By default, this means that investigators have to
commit to their protocol and analysis, thus keeping
them honest, which again leads to more believable find-
ings. There are many recognised clinical trial registries
and a list of recommended registries can be found on
the International Committee of Medical Journal Editors
website (http://www.icmje.org/publishing_j.html).
With all of this information in mind, two key points
need to be considered. Firstly, consumers of articles that
are published in JFAR should be assured that they are
reading articles that present findings from high quality
research. Secondly, potential authors of research manu-
scripts being submitted to JFAR need to adhere to the
standards set by the journal; that is, they must read the
guidelines for authors and carefully follow them when
preparing their manuscripts. The journal’s guidelines are
clear (http://www.jfootankleres.com/authors/instructions/
research) and it is now, more than ever, not acceptable for
authors to plead ignorance. As the impact of JFAR con-
tinues to increase, the editors are receiving more and
more manuscripts to be considered for publication. This
allows the editors more freedom to choose only the best
quality research articles. If a manuscript is poorly written
at the outset – for example, it has not adhered to the
journal’s guidelines – then it has a much greater chance
of rejection. Currently, JFAR rejects over 40% of the
manuscripts submitted to it, and this figure is rising as
the journal becomes more popular. For the best healthjournals in the world, such as New England Journal of
Medicine and Lancet, this figure is about 95%. This
means that they only publish the highest quality re-
search. While there are exceptions, this research will
generally be the most believable and will have the most
impact.
In conclusion, the editors of JFAR work hard to ensure
that they provide a vehicle for the best quality foot and
ankle research. While a small number of mistakes will
undoubtedly be made and errors detected only after
publication, readers can be assured that JFAR is trying to
set the highest standards possible to foster a culture of
believable research. We trust that readers of the journal
can appreciate that such standards lead to better, more
believable information for them. Some may view this as
being elitist or exclusive, but if this is the price for
believable research findings then that is a label the edi-
tors are prepared to wear. Conducting good research is
not easy, and clear evidence can sometimes take years to
compile (take the evidence for the ill-effects of tobacco
smoking as a perfect example). Journals that follow an
easy formula, where there are few checks and balances,
ultimately provide a ‘fast food’ approach to health infor-
mation – it may look fabulous and satiate ones appetite
for knowledge easily, but it is not good for anyone in the
long term. Professional journals have a responsibility to
ensure that statements made in manuscripts can be sup-
ported by the study findings (i.e. good-quality evidence).
This responsibility should not be viewed as being elitist
or exclusive and in no way suppresses freedom of expres-
sion. Indeed, the fundamental premise of scientific publi-
cation is the reporting of empirically verifiable facts, which
means believable information.
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